Invention Grant
- Patent Title: Oral compositions for the treatment of gastroesophageal reflux
-
Application No.: US16349711Application Date: 2018-09-18
-
Publication No.: US11241452B2Publication Date: 2022-02-08
- Inventor: Paola Maffei , Marco Mascagni , Giuseppe Claudio Viscomi
- Applicant: ALFASIGMA S.P.A.
- Applicant Address: IT Bologna
- Assignee: ALFASIGMA S.P.A.
- Current Assignee: ALFASIGMA S.P.A.
- Current Assignee Address: IT Bologna
- Agency: Silvia Salvadori, P.C.
- Agent Silvia Salvadori
- Priority: IT102017000108526 20170928
- International Application: PCT/EP2018/075200 WO 20180918
- International Announcement: WO2019/063363 WO 20190404
- Main IPC: A61K47/26
- IPC: A61K47/26 ; A61K47/20 ; A61K31/726 ; A61K47/12 ; A61P1/04 ; A61K9/00 ; A61K47/10 ; A61K47/36
Abstract:
The present invention describes a mucoadhesive composition comprising chondroitin sulfate, xyloglucan and glycerol for use in the treatment and prevention of gastroesophageal reflux. It is also described a process for preparing such composition, a dosage form for its administration and a kit comprising the same.
Public/Granted literature
- US20190314402A1 ORAL COMPOSITIONS FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX Public/Granted day:2019-10-17
Information query
IPC分类:
